{
 "drug": "Streptozocin Powder, For Solution",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "07/12/2022",
 "dayN": 1505,
 "cat": "Oncology",
 "companies": [
  "Teva Pharmaceuticals USA, Inc.",
  "ESTEVE PHARMACEUTICALS, S.A."
 ],
 "reasons": [
  "Other"
 ],
 "records": [
  {
   "update_type": "Revised",
   "initial_posting_date": "07/12/2022",
   "package_ndc": "0703-4636-01",
   "generic_name": "Streptozocin Powder, For Solution",
   "contact_info": "800-545-8800",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Powder, For Solution",
   "presentation": "Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/12/2022",
   "package_ndc": "68118-100-01",
   "generic_name": "Streptozocin Powder, For Solution",
   "related_info_link": "https://www.fda.gov/media/187353/download?attachment",
   "contact_info": "USSZTOrders@esteve.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA211415"
    ],
    "brand_name": [
     "QUZYTTIR"
    ],
    "generic_name": [
     "CETIRIZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "ESTEVE PHARMACEUTICALS, S.A."
    ],
    "product_ndc": [
     "68118-100"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CETIRIZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "2261746",
     "2261754"
    ],
    "spl_id": [
     "57e97eb8-9e05-8888-e063-6394a90a68de"
    ],
    "spl_set_id": [
     "573770f6-b76e-f6ba-e063-6294a90aa54d"
    ],
    "package_ndc": [
     "68118-100-02",
     "68118-100-25",
     "68118-100-10"
    ],
    "unii": [
     "64O047KTOA"
    ]
   },
   "update_date": "05/06/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Powder, For Solution",
   "presentation": "Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)",
   "company_name": "ESTEVE PHARMACEUTICALS, S.A.",
   "status": "Current"
  }
 ]
}